Radiation therapy plays an integral part in managing intracranial tumors. While the risk:benefit ratio is considered acceptable for treating malignant tumors, risks of long-term complications of radiotherapy need thorough assessment in adults treated for benign tumors. Many previously reported delayed compl...
The goal of this book chapter is to discuss the role of radiation therapy in the treatment of patients with brain metastases. New techniques permit the delivery of irradiation with a high precision on the tumor, sparing the normal brain tissue. Therefore, the tumor control increased significantly...
Radiation therapy plays an integral part in managing intracranial tumors. While the risk:benefit ratio is considered acceptable for treating malignant tumors, risks of long-term complications of radiotherapy need thorough assessment in adults treated for benign tumors. Many previously reported delayed compl...
Around 50% of patients with solid malignant tumours receive radiation therapy with curative or palliative intent at some point in the course of their disease. Early and late side effects limit radiation dose and might affect the long-term health-related quality of life of the patient. The classi...
Researchers at North Carolina State University have developed a mathematical model for computing radiation therapy treatments that could substantially reduce patient side effects while delivering the same results as conventional radiation therapy. Cancer patients who receive radiotherapy to destroy their tumors...
Radiation therapy treatscancerby using high-energy waves to kill tumor cells. The goal is to destroy or damage the cancer without hurting too many healthy cells.It is given over a certain time period; it can be given around the time of surgery or chemotherapy. It can also be used to ease...
Radiation therapy is a treatment option used for patients with persistent or recurrent hypercortisolism and residual tumors. It involves the use of modern techniques to minimize radiation exposure to normal brain tissues and requires long-term follow-up due to potential side effects. ...
Key cellular signalling pathways [1] are responsible for the response of normal tissue and tumour cells to radiation therapy [2]. Although some of the anti-cancer targets are specific for neoplastic signalling, there is considerable overlap between neoplastic signalling and normal cellular signalling....
Because the antibodies do not attack healthy cells, the possibility of radiation damage outside the tumor drops.What it's used forRadiation therapy is used to treat many types of cancer, including cancer of the lung, breast, prostate, testicles, and brain....
However, future studies are needed to optimize this strategy, as the tumor-to-blood boron ratio did not reach a therapeutic threshold. Another study stressed the need to consider the impact of prior therapy on FUS BBBO, as GBM patients will likely have had previous RT, chemotherapy, and surg...